Importantly, although our experimental findings clearly demonstrate that neutrophils from SIRS patients as well as upon in vitro serum stimulation express AAT, they do not explain how this newly synthesized AAT contributes to the inhibition of apoptosis. The gene discussed is SERPINA1; the disease is systemic inflammatory response syndrome.